BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35269894)

  • 21. [Immunohistochemical detection of p53 in colorectal cancer and its relationship to prognosis].
    Yamaguchi A; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1992 Oct; 93(10):1312-6. PubMed ID: 1435694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
    Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
    Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis.
    Rao B; Gao Y; Huang J; Gao X; Fu X; Huang M; Yao J; Wang J; Li W; Zhang J; Liu H; Wang L; Wang J
    Int J Colorectal Dis; 2011 May; 26(5):593-601. PubMed ID: 21404058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of BRAF/MIR-17 signature and B-Raf protein expression in patients with colorectal cancer: A pilot study.
    Ibrahiem AT; Fawzy MS; Abu AlSel BT; Toraih EA
    J Clin Lab Anal; 2021 Mar; 35(3):e23679. PubMed ID: 33296098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
    Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
    Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
    Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
    Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
    Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of multivariate analysis to suggest a new molecular classification of colorectal cancer.
    Domingo E; Ramamoorthy R; Oukrif D; Rosmarin D; Presz M; Wang H; Pulker H; Lockstone H; Hveem T; Cranston T; Danielsen H; Novelli M; Davidson B; Xu ZZ; Molloy P; Johnstone E; Holmes C; Midgley R; Kerr D; Sieber O; Tomlinson I
    J Pathol; 2013 Feb; 229(3):441-8. PubMed ID: 23165447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 protein accumulation as a prognostic marker in sporadic colorectal cancer.
    Lan YT; Chang SC; Li AF; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Lin JK
    Int J Colorectal Dis; 2007 May; 22(5):499-506. PubMed ID: 17021749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic effect of p53 expression in patients with completely resected colorectal cancer.
    Liu BW; Liu Y; Liu JR; Feng ZX; Liu T
    Tumour Biol; 2014 Oct; 35(10):9893-6. PubMed ID: 24993094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers.
    Sano H; Futamura M; Gaowa S; Kamino H; Nakamura Y; Yamaguchi K; Tanaka Y; Yasufuku I; Nakakami A; Arakawa H; Yoshida K
    Biochem Biophys Res Commun; 2020 Aug; 529(3):582-589. PubMed ID: 32736677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
    Zheng L; Xie G; Duan G; Yan X; Li Q
    PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.
    Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J
    Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
    Chen F; Qu M; Zhang F; Tan Z; Xia Q; Hambly BD; Bao S; Tao K
    BMC Cancer; 2020 Feb; 20(1):92. PubMed ID: 32013927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.
    Lo PK; Lee JS; Chen H; Reisman D; Berger FG; Sukumar S
    Exp Mol Pathol; 2013 Feb; 94(1):262-9. PubMed ID: 23103611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer.
    Liu H; Liu Z; Li K; Li S; Song L; Gong Z; Shi W; Yang H; Xu Y; Ning S; Ismail S; Chen Y
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1570-1580. PubMed ID: 28127799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.